AACR Project GENIE: Powering Precision Medicine through an International ConsortiumFabrice André, Gordon B. Mills, Raymond N. DuBois et al.|Cancer Discovery|2017Cited by 2k
Small molecules, big impact: 20 years of targeted therapy in oncologyPhilippe L. Bédard, Lillian L. Siu, David M. Hyman et al.|The Lancet|2020Cited by 606
A Phase Ib Dose-Escalation Study of the Oral Pan-PI3K Inhibitor Buparlisib (BKM120) in Combination with the Oral MEK1/2 Inhibitor Trametinib (GSK1120212) in Patients with Selected Advanced Solid TumorsPhilippe L. Bédard, Cristiana Sessa, Josep Tabernero et al.|Clinical Cancer Research|2014Cited by 326
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trialTracy Stockley, Philippe L. Bédard|Genome Medicine|2016Cited by 283
A phase Ib combination study of RO4929097, a gamma-secretase inhibitor, and temsirolimus in patients with advanced solid tumorsIván Díaz-Padilla, Philippe L. Bédard|Investigational New Drugs|2013Cited by 56